Related Experiment Video
Updated: Sep 10, 2025

The Importance of Correct Protein Concentration for Kinetics and Affinity Determination in Structure-function Analysis
Published on: March 17, 2010
Comprehensive Analysis of Interactions between Human Serum Albumin and Human Cystatin C - Two Proteins Present in
Adriana Żyła1, Igor Zhukov2, Michał Taube1
1Department of Biomedical Physics, Institute of Physics, Faculty of Physics and Astronomy, Adam Mickiewicz University, Poznań 61-614, Poland.
Insights
Researchers investigated interactions between human cystatin C (HCC) and human serum albumin (HSA). They confirmed complex formation using multiple methods, revealing insights into protein interactions relevant to amyloidogenesis.
Area of Science:
- Biochemistry
- Molecular Biology
- Protein Interactions
Background:
- Human cystatin C (HCC) inhibits cysteine proteases.
- Human serum albumin (HSA) is a key transport protein.
- Both proteins are implicated in amyloidogenesis.
Purpose of the Study:
- To characterize the interaction between HCC and HSA.
- To understand the binding stoichiometry and affinity.
- To explore the structural implications of complex formation.
Main Methods:
- Microscale thermophoresis (MST) for binding affinity.
- Isothermal titration calorimetry (ITC) for thermodynamic parameters.
- High-resolution mass spectrometry (HR-MS) for complex identification.
- Nuclear magnetic resonance (NMR) spectroscopy for structural dynamics.
Main Results:
- MST and ITC yielded dissociation constants (KD) around 1.15–1.3 μM.
- HR-MS confirmed HSA-HCC complex formation with 1:1 stoichiometry.
- NMR revealed altered dynamics in HCC residues upon complexation.
Conclusions:
- HSA and HCC form a stable complex with high affinity.
- The interaction dynamics provide insights into protein behavior in biological fluids.
- Findings contribute to understanding protein roles in amyloidogenesis.
Abstract:
Human cystatin C (HCC) and human serum albumin (HSA) are proteins that coexist in body fluids. The main physiological role of HCC is the inhibition of cysteine proteases, while HSA is a universal transport protein carrying numerous ligands. Both proteins are also associated with amyloidogenesis at various levels, so understanding their potential interactions is an important aspect of the research. To characterize these interactions, we used several combined complementary techniques: microscale thermophoresis (MST), isothermal titration calorimetry (ITC), high-resolution mass spectrometry (HR-MS), and nuclear magnetic resonance spectroscopy (NMR). The K D value obtained from the MST method was 1.3 μM, while the dissociation constant determined by ITC was 1.15 μM. Mass spectrometry data confirmed formation of the HSA-HCC complex with 1:1 stoichiometry. The most pronounced changes were observed in the NMR spectrum for the prolonged dynamic processes, characterized by increased spectral densities for several HCC residues.
Related Concept Videos
Drug Distribution: Plasma Protein Binding
Factors Affecting Protein-Drug Binding: Drug Interactions
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Serum Studies: Renal Function Tests
Factors Affecting Protein-Drug Binding: Protein-Related Factors
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
Drug Binding to Blood Components
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are...
Factors Affecting Protein-Drug Binding: Drug-Related Factors
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...

